Implications of HIV drug resistance on first- and second-line therapies in resource-limited settings: report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance NetworkDeenan Pillay, Jan Albert, Silvia Bertagnolio, Charles Boucher, Francoise Brun-Vezinet, Bonaventura Clotet, Carlo Giaquinto, Carlo F Perno
Corresponding author name: Deenan Pillay
Corresponding author e-mail: firstname.lastname@example.org
Citation: Antiviral Therapy 2013; 18:831-836
Date published online: 05 June 2013
Here, we summarize the discussions and conclusions from an expert workshop held in October 2012 to consider the implications of HIV drug resistance in the context of scale-up of access to antiretroviral therapy and prophylaxis in resource-limited settings. Topics considered during the workshop included the implications of drug resistance for the selection of first-line regimens and sequencing of treatments, optimal surveillance strategies and prevention of mother-to-child transmission.